These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30078657)

  • 21. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?
    Mangen MJ; van Duynhoven YT; Vennema H; van Pelt W; Havelaar AH; de Melker HE
    Vaccine; 2010 Mar; 28(14):2624-35. PubMed ID: 20109593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of rotavirus vaccination in Turkey.
    Koksal T; Akelma AZ; Koksal AO; Kutukoglu I; Ozdemir O; Yuksel CN; Bozkaya D; Catal F; Sari S
    J Microbiol Immunol Infect; 2017 Oct; 50(5):693-699. PubMed ID: 27107612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.
    Jit M; Edmunds WJ
    Vaccine; 2007 May; 25(20):3971-9. PubMed ID: 17400341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.
    Plosker GL
    Pharmacoeconomics; 2011 May; 29(5):439-54. PubMed ID: 21504245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of rotavirus vaccination programs in Taiwan.
    Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA
    Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Socio-economic modelling of rotavirus vaccination in Castilla y Leon, Spain.
    Pérez-Rubio A; Luquero FJ; Eiros Bouza JM; Castrodeza Sanz JJ; Bachiller Luque MR; de Lejarazu RO; Sánchez Porto A
    Infez Med; 2011 Sep; 19(3):166-75. PubMed ID: 22037437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia.
    Lusvan ME; Debellut F; Clark A; Demberelsuren S; Otgonbayar D; Batjargal T; Purevsuren S; Groman D; Tate J; Pecenka C
    Vaccine; 2019 Feb; 37(6):798-807. PubMed ID: 30639458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France.
    Huet F; Largeron N; Trichard M; Miadi-Fargier H; Jasso-Mosqueda G
    Vaccine; 2007 Aug; 25(34):6348-58. PubMed ID: 17629598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.
    Bruijning-Verhagen P; van Dongen JAP; Verberk JDM; Pijnacker R; van Gaalen RD; Klinkenberg D; de Melker HE; Mangen MJ
    BMC Med; 2018 Sep; 16(1):168. PubMed ID: 30196794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines.
    Cho H; Lee H; Kim DS; Kim HM; Kim JH; Kim AY; Kang HY
    Pediatr Infect Dis J; 2020 May; 39(5):460-465. PubMed ID: 31990891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
    De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
    Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage.
    Costantino C; Restivo V; Tramuto F; Casuccio A; Vitale F
    Hum Vaccin Immunother; 2018; 14(9):2297-2302. PubMed ID: 29757707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?
    Rheingans RD; Heylen J; Giaquinto C
    Pediatr Infect Dis J; 2006 Jan; 25(1 Suppl):S48-55. PubMed ID: 16397429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
    Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
    Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
    J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective.
    Smith ER; Rowlinson EE; Iniguez V; Etienne KA; Rivera R; Mamani N; Rheingans R; Patzi M; Halkyer P; Leon JS
    Vaccine; 2011 Sep; 29(38):6704-11. PubMed ID: 21624421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
    Tate JE; Kisakye A; Mugyenyi P; Kizza D; Odiit A; Braka F
    Vaccine; 2011 Apr; 29(17):3329-34. PubMed ID: 21241733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option.
    Cui S; Tobe RG; Mo X; Liu X; Xu L; Li S
    BMC Infect Dis; 2016 Nov; 16(1):677. PubMed ID: 27846803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.